Skandinaviska Enskilda Banken Ab (Publ) Aurinia Pharmaceuticals Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $21.6 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$7.77 - $12.27 $18,648 - $29,448
-2,400 Reduced 16.67%
12,000 $93,000
Q2 2023

Aug 07, 2023
BUY
$8.96 - $11.69 $129,024 - $168,336
14,400 New
14,400 $139,000
Q3 2020

Nov 12, 2020
SELL
$13.19 - $16.66 $60,674 - $76,636
-4,600 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$14.12 - $18.33 $64,952 - $84,317
4,600 New
4,600 $75,000

Others Institutions Holding AUPH

# of Institutions
223
Shares Held
59.4M
Call Options Held
1.17M
Put Options Held
1.54M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.13B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email